Stocks

The table gives an overview of all stocks, alphabetically sorted.
 C&F Financial Corporation CFFI Dec 1, 2020 37.80 +0.80   
 C.H. Robinson Worldwide, Inc. CHRW Dec 1, 2020 93.83 -0.15   
 C4 Therapeutics, Inc. CCCC Dec 1, 2020 30.23 0.00   
 Cabaletta Bio, Inc. CABA Dec 1, 2020 14.87 -0.07   
 Cabana Target Drawdown 10 ETF TDSC Dec 1, 2020 24.53 0.00   
 Cabana Target Drawdown 13 ETF TDSD Dec 1, 2020 24.75 0.00   
 Cabana Target Drawdown 16 ETF TDSE Dec 1, 2020 24.66 0.00   
 Cabana Target Drawdown 5 ETF TDSA Dec 1, 2020 23.98 0.00   
 Cabana Target Drawdown 7 ETF TDSB Dec 1, 2020 24.30 0.00   
 Cable One, Inc. CABO Dec 1, 2020 2 022.75 +2.12   
 Cabot Corporation CBT Dec 1, 2020 41.51 +0.24   
 Cabot Oil & Gas Corp. COG Dec 1, 2020 17.38 -0.80   
 CACI International, Inc. Class A CACI Dec 1, 2020 239.41 +0.89   
 Cactus, Inc. Class A WHD Dec 1, 2020 24.58 +5.95   
 Cadence Bancorporation Class A CADE Dec 1, 2020 14.30 +2.58   
 Cadence Design Systems, Inc. CDNS Dec 1, 2020 115.65 -0.56   
 Cadiz, Inc. CDZI Dec 1, 2020 10.06 +0.20   
 Cae Inc. CAE Dec 1, 2020 24.44 +0.37   
 Caesars Entertainment, Inc. CZR Dec 1, 2020 67.84 -0.41   
 Caesarstone Ltd. - Ordinary Shares CSTE Dec 1, 2020 11.62 -2.68   
 Cai International Inc FXDFR PRF PERPETUAL USD 25 - Ser A CAI-A Dec 1, 2020 26.17 +3.01   
 Cai International Inc FXDFR PRF PERPETUAL USD 25 - Ser B CAI-B Dec 1, 2020 25.92 +1.24   
 CAI International, Inc. CAI Dec 1, 2020 32.12 +1.49   
 Cal-Maine Foods, Inc. CALM Dec 1, 2020 39.59 +1.18   
 Caladrius Biosciences, Inc. CLBS Dec 1, 2020 1.50 -1.32   
 Calamos Convertible and High Income Fund CHY Dec 1, 2020 13.73 +0.22   
 Calamos Convertible Opportunities and Income Fund CHI Dec 1, 2020 12.95 +0.54   
 Calamos Dynamic Convertible & Income Fund - CCD Dec 1, 2020 27.21 +0.63   
 Calamos Global Dynamic Income Fund CHW Dec 1, 2020 9.20 +0.55   
 Calamos Global Total Return Fund CGO Dec 1, 2020 14.06 +0.57   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
Free Trial Now